Clinical trials
Phase 2 Multiple Myeloma trials in Greece
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2012 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 6 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Active, not recruiting | 5 |
| Unknown status | 5 |
| Recruiting | 3 |
| Terminated | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hellenic Society of Hematology | 5 |
| Janssen Research & Development, LLC | 4 |
| Janssen-Cilag International NV | 3 |
| Stichting European Myeloma Network | 3 |
| Bristol-Myers Squibb | 2 |
| Celgene | 2 |
| GlaxoSmithKline | 2 |
| Karyopharm Therapeutics Inc | 2 |
| Sanofi | 2 |
| Takeda | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 39 |
| Recurrence | 6 |
| Renal Insufficiency | 4 |
| Blood Protein Disorders | 3 |
| Hematologic Diseases | 3 |
| Neoplasms | 3 |
| Neoplasms, Plasma Cell | 3 |
| Paraproteinemias | 3 |
| Bone Marrow Neoplasms | 2 |
| Lymphoma | 2 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.